Cargando…

Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) ranks fifth among common cancers and is the second most common cause of cancer-related mortality worldwide. This study is aimed at identifying an immune-related long noncoding RNA (lncRNA) signature as a potential biomarker with prognostic value to improve early diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Mengqin, Wang, Yanqing, Sun, Qinqian, Liu, Shiyi, Xian, Shu, Dai, Fangfang, Zhang, Li, Fan, Yaqi, Wang, Feiyan, Yang, Dongyong, Zheng, Yajing, Deng, Zhimin, Tan, Wei, Liu, Yeqiang, Cheng, Yanxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808810/ https://www.ncbi.nlm.nih.gov/pubmed/33506049 http://dx.doi.org/10.1155/2021/9798231

Ejemplares similares

Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway
por: Yang, Dongyong, et al.
Publicado: (2021)

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
por: Liu, Shiyi, et al.
Publicado: (2020)

Correction to: CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
por: Liu, Shiyi, et al.
Publicado: (2021)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses
por: Zhang, Liping, et al.
Publicado: (2020)

Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses
por: Zhang, Liping, et al.
Publicado: (2021)

miR-21 Induces Chemoresistance in Ovarian Cancer Cells via Mediating the Expression and Interaction of CD44v6 and P-gp
por: Wang, Yanqing, et al.
Publicado: (2021)

Irisin reduces the abnormal reproductive and metabolic phenotypes of PCOS by regulating the activity of brown adipose tissue in mice(†)
por: Zheng, Yajing, et al.
Publicado: (2022)

Role of Transforming Growth Factor-β1 in Regulating Fetal-Maternal Immune Tolerance in Normal and Pathological Pregnancy
por: Yang, Dongyong, et al.
Publicado: (2021)

The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer
por: Wang, Yanqing, et al.
Publicado: (2020)

A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma
por: Nie, Ye, et al.
Publicado: (2021)

Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis
por: Dai, Fangfang, et al.
Publicado: (2019)

Integrated Bioinformatic Analysis of DNA Methylation and Immune Infiltration in Endometrial Cancer
por: Dai, Fangfang, et al.
Publicado: (2022)

A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma
por: Fan, Yaqi, et al.
Publicado: (2021)

A five lncRNA signature for prognosis prediction in hepatocellular carcinoma
por: Sun, Yongqiang, et al.
Publicado: (2019)

Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma
por: Xu, Zhijie, et al.
Publicado: (2021)

Promotion of ovarian cancer cell invasion, migration and colony formation by the miR-21/Wnt/CD44v6 pathway
por: Wang, Yanqing, et al.
Publicado: (2019)

Prediction of Recurrence in Cervical Cancer Using a Nine-lncRNA Signature
por: Mao, Yu, et al.
Publicado: (2019)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
por: Lin, Yilin, et al.
Publicado: (2020)

LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG
por: Chen, Gaoyang, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer
por: Wang, Ying, et al.
Publicado: (2022)

Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma
por: Wang, Yulu, et al.
Publicado: (2021)

Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma
por: Liu, Huiying, et al.
Publicado: (2022)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma
por: Zhang, Zhenyu, et al.
Publicado: (2022)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
por: Wang, Zitao, et al.
Publicado: (2022)

The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
por: Weng, Nuo-Qing, et al.
Publicado: (2020)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l10uq2mbm6c4f4er4cv4rmifk7